2012-present: Chair in Biomedical Science, Department of Biomedical Science, University of Sheffield, UK. 1998-2012: Programme Leader, Medical Research Council, The MRC Laboratory of Molecular Biology, Cambridge, UK. 1995-1997: Wellcome Trust Research Fellow, Imperial College, London. 1988-1991: Research Associate, Institute of Bioorganic Chemistry, Moscow.

We are working on biomolecular assembly, neuronal blockers, medicines for chronic pain, anti-cancer biological drugs.

Mangione AS, Obara I, Maiarú M, Geranton SM, Tassorelli C, Ferrari E, Leese C, Davletov B & Hunt SP (2016) Nonparalytic botulinum molecules for the control of pain. PAIN, 157(5), 1045-1055. View this article in White Rose Research Online Dolgacheva LP, Turovskaya MV, Dynnik VV, Zinchenko VP, Goncharov NV, Davletov B & Turovsky EA (2016) Angiotensin II activates different calcium signaling pathways in adipocytes. Archives of Biochemistry and Biophysics, 593, 38-49. Rust A, Leese C, Binz T & Davletov B (2016) Botulinum neurotoxin type C protease induces apoptosis in differentiated human neuroblastoma cells. Oncotarget. View this article in White Rose Research Online Mavlyutov TA, Duellman T, Kim HT, Epstein ML, Leese C, Davletov BA & Yang J (2016) Sigma-1 receptor expression in the dorsal root ganglion: Reexamination using a highly specific antibody. Neuroscience, 331, 148-157.